{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:19:25Z","timestamp":1776269965838,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T00:00:00Z","timestamp":1314144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There was a pandemic influenza around the world in 2009 including South Korea since last pandemic occurred four decades ago. We aimed to evaluate the epidemiological and clinical characteristics of this infection in childhood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We evaluated the epidemiologic characteristics of all the subjects infected with the 2009 H1N1 influenza A virus (2,971 patients, \u2264 15 years of age), and the clinical and laboratory findings of the inpatients (217 patients, 80 had pneumonia) between 1 September 2009 and 31 January 2010 in a single hospital throughout the epidemic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The age distribution of all the subjects was relatively even. Over 90% of cases occurred during a two-month period. Two hundred and five patients (94.5%) received oseltamivir within 48 h of fever onset, and 97% of inpatients defervesced within 48 h of medication. The group with pneumonia included more males than females, and had higher leukocytes counts with lower lymphocyte differentials than the group without pneumonia. The white blood cell count and lymphocyte differential were associated with the severity of pneumonia. Corticosteroid treatment for severe pneumonia patients was highly effective in preventing disease progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Children of all ages affected with even rates of infection, but males were predominant in pneumonia patients. Pneumonia patients showed lymphopenia and its severity was associated with the severity of illness. Our results suggest that the mechanism of lung injury in 2009 H1N1 virus infection may be associated with the host immune response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-11-225","type":"journal-article","created":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T18:26:29Z","timestamp":1314210389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: an observational cohort study"],"prefix":"10.1186","volume":"11","author":[{"given":"Jung-Woo","family":"Rhim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Yil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Sook","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Chang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,24]]},"reference":[{"key":"1563_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature08157","volume":"459","author":"G Neumann","year":"2009","unstructured":"Neumann G, Noda T, Kawaoka Y: Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009, 459: 931-939. 10.1038\/nature08157.","journal-title":"Nature"},{"key":"1563_CR2","first-page":"423","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention: Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. Morb Mortal Wkly Rep. 2010, 59: 423-430.","journal-title":"Morb Mortal Wkly Rep"},{"key":"1563_CR3","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1056\/NEJMp0910445","volume":"361","author":"JF Bishop","year":"2010","unstructured":"Bishop JF, Mumane MP, Owen R: Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2010, 361: 2591-1594.","journal-title":"N Engl J Med"},{"key":"1563_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1086\/650750","volume":"50","author":"JP Torres","year":"2010","unstructured":"Torres JP, O'Ryan M, Herve B, Espinoza R, Acuna G, Manalich J, Chomali M: Impact of the novel influenza A (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis. 2010, 50: 860-868. 10.1086\/650750.","journal-title":"Clin Infect Dis"},{"key":"1563_CR5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMra1000449","volume":"362","author":"Wriging commitee of the WHO consultaton on clinical aspect of pandemic (H1N1) 2009 influenza","year":"2010","unstructured":"Wriging commitee of the WHO consultaton on clinical aspect of pandemic (H1N1) 2009 influenza: Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010, 362: 1708-1719.","journal-title":"N Engl J Med"},{"key":"1563_CR6","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa0908481","volume":"361","author":"The ANZIC Influenza Investigators","year":"2009","unstructured":"The ANZIC Influenza Investigators: Critical care services and 2009 H1N1 influenza in Australia and Newzaeland. New Engl J Med. 2009, 361: 1925-1934.","journal-title":"New Engl J Med"},{"key":"1563_CR7","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1001\/jama.2009.1496","volume":"302","author":"A Kumar","year":"2009","unstructured":"Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Canadian Critical Care Trials Group H1N1 Collaborative, et al: Critically ill patients with 2009 influenza A (H1N1) Infection in Canada. JAMA. 2009, 302: 1872-1879. 10.1001\/jama.2009.1496.","journal-title":"JAMA"},{"key":"1563_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/vim.2007.0017","volume":"20","author":"MC Eichelberger","year":"2007","unstructured":"Eichelberger MC: The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol. 2007, 20: 243-249. 10.1089\/vim.2007.0017.","journal-title":"Viral Immunol"},{"key":"1563_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mehy.2010.08.032","volume":"76","author":"KY Lee","year":"2011","unstructured":"Lee KY, Rhim JW, Kang JH: Hyperactive immune cells (T cells) may be Responsible for acute lung injury in influenza virus infections: a need for early Immune-modulators for severe cases. Med Hypotheses. 2011, 76: 64-69. 10.1016\/j.mehy.2010.08.032.","journal-title":"Med Hypotheses"},{"key":"1563_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/cc10082","volume":"22","author":"HR Kil","year":"2011","unstructured":"Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH: Early corticoid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Crit Care. 2011, 22: 413-","journal-title":"Crit Care"},{"key":"1563_CR11","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","volume":"360","author":"Novel Swine-Origin Influenza a (H1N1) Virus Investigation Team","year":"2009","unstructured":"Novel Swine-Origin Influenza a (H1N1) Virus Investigation Team: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009, 360: 2605-2615.","journal-title":"N Engl J Med"},{"key":"1563_CR12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S0140-6736(09)62126-7","volume":"375","author":"E Miller","year":"2010","unstructured":"Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M: Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serologic study. Lancet. 2010, 375: 1100-1118. 10.1016\/S0140-6736(09)62126-7.","journal-title":"Lancet"},{"key":"1563_CR13","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","volume":"361","author":"S Jain","year":"2009","unstructured":"Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L, Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team: Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009, 361: 1935-1944. 10.1056\/NEJMoa0906695.","journal-title":"N Engl J Med"},{"key":"1563_CR14","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1016\/j.vaccine.2010.02.044","volume":"28","author":"JA Bettinger","year":"2010","unstructured":"Bettinger JA, Sauv\u00e9 LJ, Scheifele DW, Moore D, Vaudry W, Tran D, Halperin SA, Pelletier L: Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine. 2010, 28: 3180-3184. 10.1016\/j.vaccine.2010.02.044.","journal-title":"Vaccine"},{"key":"1563_CR15","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1001\/jama.2009.1583","volume":"302","author":"JK Louie","year":"2009","unstructured":"Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009, 302: 1896-1902. 10.1001\/jama.2009.1583.","journal-title":"JAMA"},{"key":"1563_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1503\/cmaj.091724","volume":"182","author":"S O'Riodan","year":"2009","unstructured":"O'Riodan S, Barton M, Yau Y, Reed SE, Allen U, Tran D: Risk factors and outcoms among children admitted to hospital with pandemic H1N1 influenza. CMJA. 2009, 182: 39-44.","journal-title":"CMJA"},{"key":"1563_CR17","volume-title":"Pandemic influenza A (H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010","author":"O Wichmann","year":"2010","unstructured":"Wichmann O, St\u00f6cker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, Krause G, Eckmanns T: Pandemic influenza A (H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill. 2010, 15 (18): pii:19561"},{"key":"1563_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jcv.2010.01.007","volume":"47","author":"O Co\u015fkun","year":"2010","unstructured":"Co\u015fkun O, Sener K, Yaman H, Bodur H, Eyig\u00fcn CP: Relative lymphopenia and monocytosis may be considered as a surrogate marker of pandemic influenza A (H1N1). J Clin Viol. 2010, 47: 388-389.","journal-title":"J Clin Viol"},{"key":"1563_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1179\/146532810X12637745452031","volume":"30","author":"A Saha","year":"2010","unstructured":"Saha A, Jha N, Dubey NH, Gupta VK, Kalaivani M: Swine-origin influenza A (H1N1) in Indian children. Ann Trop Pediatr. 2010, 30: 51-5. 10.1179\/146532810X12637745452031.","journal-title":"Ann Trop Pediatr"},{"key":"1563_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3201\/eid1501.080073","volume":"15","author":"ND Hien","year":"2009","unstructured":"Hien ND, Ha NH, Van NT, Ha NTM, Lien TTM, Thai NQ, Trang VD, Shimbo T, Takahashi Y, Kato Y, Kawana A, Akita S, Kudo K: Human infection with highly pathogenic avian influenza virus (H5N1) in Northern Vietnam, 2004-2005. Emerg Infect Dis. 2009, 15: 19-23. 10.3201\/eid1501.080073.","journal-title":"Emerg Infect Dis"},{"key":"1563_CR21","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1128\/JVI.74.13.6105-6116.2000","volume":"74","author":"TM Tumpey","year":"2000","unstructured":"Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM: Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol. 2000, 74: 6105-6116. 10.1128\/JVI.74.13.6105-6116.2000.","journal-title":"J Virol"},{"key":"1563_CR22","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","volume":"12","author":"MD De Jong","year":"2006","unstructured":"De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chan NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006, 12: 1203-1207. 10.1038\/nm1477.","journal-title":"Nat Med"},{"key":"1563_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3181\/00379727-146-38047","volume":"146","author":"F Suzuki","year":"1974","unstructured":"Suzuki F, Ghya J, Ishida N: Effect of antilymphocyte serum on influenza virus infection in mice (38047). Proc Soc Exp Biol Med. 1974, 146: 78-84.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1563_CR24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/iai.15.1.221-229.1977","volume":"15","author":"PR Wyde","year":"1977","unstructured":"Wyde PR, Couch RB, Mackler BF, Cate TR, Levy BM: Effect of low- and high-passage influenza virus infection in normal and nude mice. Infect and Immun. 1977, 15: 221-229.","journal-title":"Infect and Immun"},{"key":"1563_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1086\/650581","volume":"50","author":"KK To","year":"2010","unstructured":"To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, Luk WK, Lai KY, Chow FL, Mok T, Buckley T, Chan JF, Wong SS, Zheng B, Chen H, Lau CC, Tse H, Cheng VC, Chan KH, Yuen KY: Delayed clearance of viral load and marked cytoline activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010, 50: 850-859. 10.1086\/650581.","journal-title":"Clin Infect Dis"},{"key":"1563_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Porta RD, Giorgio C, Blasi F, Umberger R, Meduri GU: Hydrocortisone infusion for severe community-acquired pneumonia. A preliminary randomized study. Am J Respi Crit Care Med. 2005, 171: 242-248.","journal-title":"Am J Respi Crit Care Med"},{"key":"1563_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.201102-0345ED","volume":"183","author":"D Annane","year":"2011","unstructured":"Annane D: Pro: The illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am J Respir Crit Care Med. 2011, 183: 1125-1126. 10.1164\/rccm.201102-0345ED.","journal-title":"Am J Respir Crit Care Med"},{"key":"1563_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijantimicag.2010.01.006","volume":"35","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J: Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Intern J Antimicrob Agents. 2010, 35: 421-430. 10.1016\/j.ijantimicag.2010.01.006.","journal-title":"Intern J Antimicrob Agents"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-225\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:15:59Z","timestamp":1630512959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-225","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,24]]},"assertion":[{"value":"3 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"225"}}